Massmutual Trust CO Fsb Regenxbio Inc. Transaction History

Massmutual Trust CO Fsb

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 03, 2024	BUY	$12.89 - $20.82 $979 - $1,582	76 New	76 $1,000
Q2 2023 Aug 01, 2023	BUY	$17.23 - $21.71 $5,668 - $7,142	329 New	329 $6,000
Q4 2022 Jan 06, 2023	BUY	$20.4 - $24.73 $1,060 - $1,285	52 New	52 $1,000
Q2 2022 Jul 07, 2022	SELL	$19.35 - $35.04 $3,366 - $6,096	-174 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$26.52 - $49.35 $2,492 - $4,638	94 Added 117.5%	174 $8,000

Q3 2020 Nov 13, 2020	BUY	$27.01 - $40.26 $2,160 - $3,220	80 New	80 $2,000

192

42.6M

80.6K

55.2K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $590M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

Stay updated on Massmutual Trust CO Fsb with notifications on news.